Skip to main content
. Author manuscript; available in PMC: 2024 Apr 6.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S81–S88. doi: 10.1097/QAI.0000000000002637

Table 1.

HIV-related characteristics of 1,363 enumeration areas with at least one HIV-positive adult, participating in Population-based HIV Impact Assessment surveys in Zambia, Zimbabwe and Malawi (2015–2016)

Mean Jackknife Std. Err. (95% CI)
Age of the female population in the EA (years) 30.2 0.02 (30.2–30.3)
Age of the male population in the EA (years) 30.0 0.03 (30.0–30.1)
Number of survey adult participants in the EA 43 0.55 (42–44)
Proportion of adults ever tested for HIV in the EA 74.5% 0.3% (74.0–75.0)
HIV prevalence in the EA 13.1% 0.2% (12.7–13.5)
Proportion of PLHIV aware of their HIV status 74.9% 0.6% (73.7–76.1)
Proportion of PLHIV currently on ART 66.5% 0.7% (65.2–67.9)
Prevalence of virologic suppression (VL< 1000 copies/mL) 58.7% 0.7% (57.3–60.0)
Prevalence of viremia with VL≥ 1000 copies/mL 38.2% 0.7% (36.9–39.6)
Prevalence of viremia with VL≥ 400 copies/mL 40.2% 0.7% (38.8–41.6)
Prevalence of viremia with VL≥ 40 copies/mL 46.3% 0.7% (44.8–47.7)

Note:

ART: antiretroviral therapy

EA: Enumeration area

PLHIV: People living with HIV

VL: Viral load